Debentures (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | 9 Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 21, 2017 |
Sep. 19, 2017 |
Jul. 17, 2017 |
Mar. 21, 2017 |
Feb. 07, 2017 |
Feb. 02, 2017 |
Mar. 31, 2016 |
Sep. 30, 2017 |
Mar. 31, 2017 |
Sep. 30, 2017 |
Sep. 30, 2017 |
Sep. 30, 2017 |
Sep. 30, 2016 |
Jun. 30, 2017 |
Jun. 22, 2017 |
Jun. 02, 2017 |
Mar. 15, 2017 |
|
| Warrants to purchase common stock | 2,056 | ||||||||||||||||
| Debt instrument maturity date | Aug. 31, 2017 | ||||||||||||||||
| Proceeds from debt | $ 15,700,000 | ||||||||||||||||
| Repayment of debt | $ 500,000 | ||||||||||||||||
| Convertible debt | $ 20,962,234 | $ 20,962,234 | $ 20,962,234 | 20,962,234 | |||||||||||||
| Interest expenses | $ 41,000,000 | (8,441,043) | |||||||||||||||
| Non-cash interest and amortization of debt discount expense | 4,800,000 | 14,700,000 | |||||||||||||||
| Proceeds from issuance warrants | 15,700,000 | ||||||||||||||||
| Amortization of debt discount | (6,228,352) | $ (2,474,497) | |||||||||||||||
| Reserve stock split, description | 1-for-15 reverse stock split effective October 5, 2017 | 1-for-30 reverse stock split of the Company’s shares of common stock effective on February 22, 2017 | |||||||||||||||
| Proceeds from issuance of debenture and warrants | 15,700,000 | ||||||||||||||||
| Unamortized Discount | $ 16,398,666 | $ 16,398,666 | $ 16,398,666 | 16,398,666 | |||||||||||||
| June Warrants [Member] | Accredited Investor [Member] | |||||||||||||||||
| Warrant purchase price | 1,902,700 | ||||||||||||||||
| Proceeds from issuance warrants | 1,500,000 | ||||||||||||||||
| March Offerings [Member] | March Warrants and Exchange Warrants [Member] | |||||||||||||||||
| Debt instrument original amount | $ 41,300,000 | ||||||||||||||||
| March Offerings [Member] | Debenture Warrant [Member] | |||||||||||||||||
| Debenture description | The Company recognized a discount for 100% of the principal value of the March Debentures and the Exchange Debentures and non-cash interest expense in the amount of $43.7 million in connection with the recognition of these derivative liabilities. | ||||||||||||||||
| February Offering [Member] | |||||||||||||||||
| Debt instrument face amount | $ 1,600,000 | ||||||||||||||||
| Warrants to purchase common stock | 6,667 | ||||||||||||||||
| Warrant exercise price | $ 38.70 | ||||||||||||||||
| Warrant purchase price | $ 1,500,000 | ||||||||||||||||
| Debt instrument of exchange price | $ 2,500,000 | ||||||||||||||||
| March Offerings [Member] | |||||||||||||||||
| Debt instrument face amount | $ 10,850,000 | ||||||||||||||||
| Debt instrument maturity date | Mar. 21, 2019 | ||||||||||||||||
| Proceeds from debt | $ 8,400,000 | ||||||||||||||||
| Repayment of debt | 750,000 | ||||||||||||||||
| Convertible debt | 2,500,000 | ||||||||||||||||
| Interest expenses | 400,000 | ||||||||||||||||
| Stock converted into debt | 2,700,000 | ||||||||||||||||
| March Offerings [Member] | Series H Convertible Preferred Stock [Member] | |||||||||||||||||
| Stock of convertible preferred stock | 2,200,000 | ||||||||||||||||
| 2017 Diamantis Note [Member] | March Offerings [Member] | |||||||||||||||||
| Repayment of debt | $ 3,800,000 | ||||||||||||||||
| March Debentures and Exchange Debenture [Member] | March Offerings [Member] | |||||||||||||||||
| Warrants to purchase common stock | 9,166,616 | 9,166,616 | 9,166,616 | 9,166,616 | |||||||||||||
| Debt instrument maturity date | Mar. 21, 2019 | ||||||||||||||||
| Stock converted into debt | $ 548,932 | ||||||||||||||||
| Debt original issue discount, percentage | 24.00% | ||||||||||||||||
| Debenture description | The March Debentures and Exchange Debentures are convertible into shares of the Company’s common stock, which has been adjusted pursuant to the terms of the March Debentures to $5.85 per share as of September 30, 2017, due to prices at which the Company has subsequently issued shares of common stock). The March Debentures began to amortize monthly commencing on the 90th day following the closing date. The Exchange Debentures began to amortize monthly on the closing date. On each monthly amortization date, the Company may elect to repay 5% of the original principal amount of March Debentures and Exchange Debentures in cash or, in lieu thereof, the conversion price of such debentures will thereafter be 85% of the volume weighted average price at the time of conversion. | ||||||||||||||||
| Stock converted into debt, value | 4,100,000 | ||||||||||||||||
| Debt instrument original amount | $ 15,300,000 | ||||||||||||||||
| March Debentures and Exchange Debenture [Member] | March Offerings [Member] | Series A Warrant [Member] | |||||||||||||||||
| Warrants to purchase common stock | 3,214,911 | 3,214,911 | 3,214,911 | 3,214,911 | |||||||||||||
| Warrant exercise price | $ 5.85 | $ 5.85 | $ 5.85 | $ 5.85 | |||||||||||||
| Warrant term | 5 years | ||||||||||||||||
| March Debentures and Exchange Debenture [Member] | March Offerings [Member] | Series B Warrant [Member] | |||||||||||||||||
| Warrants to purchase common stock | 2,736,794 | 2,736,794 | 2,736,794 | 2,736,794 | |||||||||||||
| Warrant exercise price | $ 5.85 | $ 5.85 | $ 5.85 | $ 5.85 | |||||||||||||
| Warrant term | 18 months | ||||||||||||||||
| March Debentures and Exchange Debenture [Member] | March Offerings [Member] | Series C Warrant [Member] | |||||||||||||||||
| Warrants to purchase common stock | 3,214,911 | 3,214,911 | 3,214,911 | 3,214,911 | |||||||||||||
| Warrant exercise price | $ 5.85 | $ 5.85 | $ 5.85 | $ 5.85 | |||||||||||||
| Warrant term | 5 years | ||||||||||||||||
| June Debentures [Member] | June Offerings [Member] | |||||||||||||||||
| Warrants to purchase common stock | 100,000 | ||||||||||||||||
| June Offerings [Member] | |||||||||||||||||
| Warrants to purchase common stock | 66,667 | 33,333 | |||||||||||||||
| Warrant exercise price | $ 5.70 | $ 5.85 | |||||||||||||||
| July Offerings [Member] | |||||||||||||||||
| Debt instrument face amount | $ 4,136,862 | ||||||||||||||||
| Warrants to purchase common stock | 141,333 | ||||||||||||||||
| Warrant exercise price | $ 5.63 | $ 5.63 | $ 5.63 | $ 5.63 | |||||||||||||
| Debt instrument of exchange price | $ 1,902,700 | ||||||||||||||||
| Warrant term | 5 years | ||||||||||||||||
| Warrant consideration in cash | $ 2,000,000 | ||||||||||||||||
| Reserve stock split, description | 1-for-8 reverse split | ||||||||||||||||
| July Offerings [Member] | October 5 2017 [Member] | |||||||||||||||||
| Reserve stock split, description | 1-for-15 reverse stock split | ||||||||||||||||
| July Debentures [Member] | |||||||||||||||||
| Debt instrument of exchange price | $ 6,400,000 | ||||||||||||||||
| September Offerings [Member] | |||||||||||||||||
| Debt instrument face amount | 2,604,000 | ||||||||||||||||
| Debt instrument of exchange price | 4,136,862 | ||||||||||||||||
| Interest expenses | $ 1,000,000 | ||||||||||||||||
| Debt original issue discount, percentage | 24.00% | 24.00% | 24.00% | 24.00% | |||||||||||||
| Debenture description | The September Debentures begin to amortize monthly commencing on the earlier of the 90th day following September 19, 2017 or the effective date of a registration statement covering the shares of common stock issuable upon conversion of the September Debentures. On each monthly amortization date, the Company may elect to repay 5% of the original principal amount of September Debentures in cash or, in lieu thereof, the conversion price of such September Debentures shall thereafter be 85% of the volume weighted average price at the time of conversion. | ||||||||||||||||
| Proceeds of offering cost | $ 2,100,000 | ||||||||||||||||
| September Offerings [Member] | Series A Warrant [Member] | |||||||||||||||||
| Warrants to purchase common stock | 6,935,517 | 2,311,829 | 2,311,829 | 2,311,829 | 2,311,829 | ||||||||||||
| Warrant exercise price | $ 3.90 | $ 3.90 | $ 3.90 | $ 3.90 | |||||||||||||
| Warrant term | 5 years | ||||||||||||||||
| September Offerings [Member] | Series B Warrant [Member] | |||||||||||||||||
| Warrants to purchase common stock | 6,935,517 | 2,311,859 | 2,311,859 | 2,311,859 | 2,311,859 | ||||||||||||
| Warrant exercise price | $ 3.90 | $ 3.90 | $ 3.90 | $ 3.90 | |||||||||||||
| Warrant term | 18 months | ||||||||||||||||
| September Offerings [Member] | Series C Warrant [Member] | |||||||||||||||||
| Warrants to purchase common stock | 6,935,517 | 2,311,829 | 2,311,829 | 2,311,829 | 2,311,829 | ||||||||||||
| Warrant exercise price | $ 3.90 | $ 3.90 | $ 3.90 | $ 3.90 | |||||||||||||
| Warrant term | 5 years | ||||||||||||||||
| September Debenture [Member] | |||||||||||||||||
| Debt instrument of exchange price | $ 6,412,136 | ||||||||||||||||
| Amortization amount | $ 100,000 | ||||||||||||||||